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The role of airway wall remodelling in bronchial asthma is well established. Myofibroblasts, the
cells displaying features intermediate between fibroblasts and smooth muscle cells, are
involved in this process but the mechanism of myofibroblasts activation in the onset of the
disease remains obscure. Myofibroblasts can differentiate from various cell types, including
resident fibroblasts, and the fibroblasts to myofibroblasts transition (FMT) can be reproduced
in vitro. We aimed to investigate the process of FMT in human bronchial fibroblasts (HBF)
derived from non-asthmatic (n Z 7) and asthmatic (n Z 7) subjects. We also tested whether
cellecell contacts affect FMT by using N-cadherin blocking antibody. HBF plated in low or high
cell density were treated with TGF-b1 up to one week to induce FMT. The percentage of myo-
fibroblsts was counted and expression of asmooth muscle actin was evaluated by cytoimmu-
nofluorescence, flow cytometry and immunobloting. We demonstrated that the intensity of
FMT induced by TGF-b1 in vitro was strongly enhanced in asthmatic as compared to non-
asthmatic HBF populations. This process was facilitated by low cell plating density in both
groups of cultures. Furthermore, we proved that neither HBF-conditioned medium nor growth
arrest in G0/G1 phase of cell cycle could stop the TGF-b1-induced FMT in asthmatic cell popu-
lations. However, even in sparse asthmatic HBF, the blocking of N-cadherin resulted in the inhi-
bition of FMT. Our findings show for the first time that the initial absence or an induced loss of
cellecell adhesions in asthmatic HBF populations is important for the completion of FMT.
ª 2011 Elsevier Ltd. All rights reserved.664 61 44; fax: þ48 12 664 69 02.
j.edu.pl (M. Michalik).
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males, 5 females; average age: 41 years; mean duration ofMyofibroblasts represent a heterogeneous group of cells
displaying a phenotype intermediate between fibroblasts
and smooth muscle cells. Myofibroblasts predominantly
differentiate from tissue-specific fibroblasts, but can also
originate from bone marrow-derived fibrocytes, tissue-
derived stem cells, epithelial and smooth muscle cells.1e3
In particular, wound healing depends on myofibroblast
activity.4,5 However, these cells - armed with the capacity
of soft tissue remodelling - are also able to determine the
incitement and maintenance of chronic fibrocontractive
diseases.5e7
The tissue remodelling seems to be accomplished by
myofibroblasts in both a mechanical and biochemical
manner. Incorporation of de novo expressed a-smooth
muscle actin (a-SMA) into stress fibres enables the forma-
tion of “supermature focal adhesions” (FAs) as well as
specific cellecell adherents junctions (AJs)8,9 which help
myofibroblasts to develop a high contractile activity.10,11
Furthermore, the special pattern of synthesis and secre-
tion of ECM components and growth factors, matrix met-
alloproteinases and their inhibitors participates in the
remodelling of relevant tissues.12,13
Significantly, both systems shown to be responsible for
fibroblasts to myofibroblasts transition (FMT) were also pin-
pointed as crucial for the development of bronchial asthma.
Phenotypic FMT requires local accumulation of biologically
active TGF-b14,15 as well as the presence of specific ECM
proteins.16 Furthermore, the mechanical tension generated
by myofibroblasts, and dependent on cell-ECM and cellecell
contacts, seems to play a role in this process.10,17 In fact, the
structural changes of the bronchial wall resulting from the
myofibroblast activity, together with chronic inflammation,
are fundamental factors in the process of the remodelling of
the airways.3,12,18 It was recently demonstrated that bron-
chial fibroblasts derived from asthmatic patients display
in vitro a high potential to differentiate into myofibro-
blasts.19,20 Moreover the capacity of fibroblast differentia-
tion towards myofibroblastic phenotype is enhanced at low
cell density.21,22 In this study we aimed to elucidate the
effect of cell density and intercellular contacts in the
cultures of non-asthmatic and asthmatic bronchial fibroblast
populations on the process of FMT.
Material and methods
Isolation and culture of human bronchial fibroblasts
(HBF)
Primary HBF were isolated from bronchial biopsies as
described previously.23 Fibroblasts were derived from two
groups comprising in a total number of 14 individuals. The
first group consisted of 7 nonasthmatics in whom diagnostic
bronchoscopy ruled out any serious airway pathology,
including asthma, fibrotic lung disease, sarcoidosis, and
cancer (group NA: 2 males and 5 females; average age: 46
years; mean forced expiratory volume in the first second
(FEV1): 112% predicted, range: 97e138%). The second group
consisted of 7 patients diagnosed with asthma (group AS: 2asthma: 7 years; mean FEV1%: 77.2% of predicted, range:
40e109%). All patients were treated in the Department of
Medicine of Jagiellonian University and were in stable
clinical condition. The study was approved by the Uni-
versity’s Ethics Committee (KBET/362/B/2003) and all the
patients provided informed consent to participate.
Cells were cultured in DMEM with 10% foetal bovine
serum (FBS) at 37 C in a humidified atmosphere with 5%
CO2 and used between 5 and 15 passages. For experiments,
cells were plated at low (5000 cells/cm2) or high
(50,000 cells/cm2) density and cultured in serum-free DMEM
supplemented with 0.1% bovine serum albumin (BSA)
(Sigma St. Louis, USA) with or without human recombinant
TGF-b1 (PeproTech EC, London, UK).
Generation of fibroblast-conditioned medium
HBF from AS group were plated at high density (50,000
cells/cm2) in 10 cm diameter dishes in DMEM supplemented
with 10% FBS for 24 h and then the medium was aspirated
and cells were incubated in DMEM supplemented with 0.1%
BSA and with 5 ng/ml TGF-b1 for 3 or 5 days. This condi-
tioned medium was then collected, filtered through
a 0.4 mm filtration unit, and used for the experiments.
Immunofluorescence
The myofibroblasts were identified by immunodetection of
a-SMA. The cells growing on glass coverslips were washed
with PBS, fixed in 3.7% paraformaldehyde for 15 min, and
permeabilized in 0.1% Triton X-100 for 10 min at room
temperature. Following fixation, slides were blocked with
3% BSA for 30 min. Subsequently, slides were incubated
with the mouse monoclonal antibody against human a-SMA
(clone 1A4, SigmaeAldrich, 1:400) for 1 h at room
temperature. Cells were washed 5 times with PBS and
incubated with Alexa Fluor 488 goat anti-mouse IgG (clone,
SigmaeAldrich, 1:200) for 45 min at room temperature. For
staining of actin filaments TRITC-phalloidin (500 ng/ml,
SigmaeAldrich) was used. Fluorescent images were taken
with a Leica DMIRE2 microscope.
Flow cytometry
Primary bronchial fibroblasts were seeded at the concen-
tration of 5000 cells/cm2 (low density) or 50,000 cells/cm2
(high density) into 6-well plates and cultured overnight in
DMEM supplemented with 10% FBS. Then the culturemedium
was changed for serum-reduced medium with or without
TGF-b1 (5 ng/ml). On day 7, fibroblasts were trypsinized and
prepared for immunostaining. Detached cells were washed,
fixed in 1% paraformaldehyde and permeabilised with 0.1%
Triton X-100. To minimise non-specific binding, cells were
blocked by incubation in 10% FBS in PBS. Expression of a-SMA
was assessed with anti-a-SMA antibody and the specificity of
staining was confirmed with mouse-IgG2a isotype control
used at the same concentration. The cell suspensions were
kept overnight at 4 C, washed in 0.01% Triton X-100 PBS
buffer, stained for 45 min with secondary FITC-conjugated
goat anti-mouse IgG (SigmaeAldrich), and analysed by flow
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CA). Results were expressed as a ratio of mean fluorescent
intensity (MFI) of a-SMA labelled sample to MFI of corre-
sponding isotype control sample.
Preparation of cell extracts and immunoblotting
Cells were cultured in cell culture Petri dishes until con-
fluency. The cells were stimulated with TGF-b1 (5 ng/ml)
for 7 days. Fibroblasts were lysed with the lysis buffer
(0.1 mol/L Tris-HC1, 15% glycerol, 2 mM EDTA, 2% SDS,Figure 1 TGF-b1 induced differentiation of HBF into myofibrobla
non-asthmatics (NA: nZ 5) and asthmatics (AS: nZ 5) were culture
0.1% BSA with 5 ng/ml TGF-b1 for 3, 5 and 7 days. The cells were fixe
(myofibroblasts) was counted. Each point represents the result ob
groups (NA and AS cultures), respectively (B). The results presented
culture. The statistical analysis was performed using ManneWhitney
(C) The graph illustrates the lack of correlation between the numb
asthmatic patients and the asthma severity (FEV1%) of the donors10 mM phenylmethytsulfonyl fluoride, and 10 mg/mL apro-
tinin, pH 7.4), and 10 mg of total cellular protein was sub-
jected to SDS-PAGE in 15% acrylamide gels under reducing
conditions and transferred into polyvinylidene difluoride
membrane (Hybond-P, Amersham Pharmacia Biotech).
After blocking in PBS-T (0.1% Tween 80 in PBS) containing
5% skimmed milk at room temperature, the membrane was
incubated for 1 h with mouse monoclonal anti-a-SMA anti-
body (1:1000 in 3% BSA in PBS). After washing 3 times, the
membrane was incubated for 1 h with anti-mouse IgG
horseradish peroxidase-conjugated antibody (1:3000 insts depends on the duration of the factor-treatment. HBF from
d in DMEM with 10% FCS for 24 h, then with DMEM supplemented
d and stained for a-SMA and the number of a-SMA positive cells
tained from particular cultures (A) or the mean values of both
are the means of at least three separated experiments for each
U-test, )- p < 0.01 between groups of subjects (AS versus NA).
er of TGF-b1-induced a-SMA positive cells in HBF derived from
(AS: n Z 5).
1470 M. Michalik et al.PBS-T containing 5% skimmed milk; Santa Cruz Biotech-
nology). The extensively washed membranes were incu-
bated with chemiluminescent reagent (ECL-Western
blotting analysis system, Amersham) for 5 min and exposed
to Kodak X-Omat film.
Results
“Asthmatic” HBF populations are more prone to
FMT
First experiments were aimed to compare a time-
dependence of FMT in NA and AS HBF cell populations
undergoing a long-lasting TGF-b1 treatment. Analyses of
a-SMA-positive cells in NA and AS cell populations per-
formed on day 3, 5 and 7 after TGF-b1 stimulation revealed
an increase in the percentage of myofibroblasts in both
analysed groups (Fig. 1). However, FMT was much more
frequent in asthmatic HBF cell populations (NA, between 9Figure 2 HBF differentiation into myofibroblasts is cell densit
asthmatics (AS: nZ5) were plating at low (5000 cells/cm2) and high
for 24 h, then with DMEM supplemented with 0.1% BSA and 5 ng/ml T
of positive cells was counted. (B) Cells from representative non-asth
Nomarski interference contrast optics and with epifluorescence mo
myofibroblasts whereas in identical high-density culture only few a
the confluent fibroblasts. Bar Z 50 mm.and 40%; AS, between 70 and 95% on day 7). These data
demonstrate differences in the potential of non-asthmatic
and asthmatic fibroblasts to differentiate into myofibro-
blasts in response to TGF-b1, and show that this process is
time-dependent. It is striking that the lowest FMT level in
AS group is much higher than the highest value in NA group.
However, no significant correlation between TGF-
b1induced FMT potential and the asthma severity (FEV1%)
of the donors could be observed (Fig. 1C). Although the
study group of asthmatics is too small to drive the final
conclusion it can be assumed that the enhanced potential
of FMT occurs throughout the spectrum of asthma severity.
FMT level is dependent on HBF culture density
We further compared TGF-b1-reactiveness of NA and AS
bronchial fibroblasts plated at 5000 cells/cm2 (low density)
and 50000 cells/cm2 (high density cells) to elucidate density-
dependence of FMT. When AS HBF were incubated in the
presence of TGF-b1 for 7 days, a decreased level of FMT wasy-dependent. (A) HBF from non-asthmatics (NA: n Z 5) and
(50,000 cells/cm2) density and cultured in DMEM with 10% FCS
GF-b1 for 7 days. Cells were stained for a -SMA and the number
matic (NA) and asthmatic (AS) culture were photographed with
de. Note that majority of cells in low-density AS culture were
-SMA-staining cells appear to be growing surprisingly on top of
Figure 3 The cytometric analysis of a-SMA expression in HBF
plated at low or high density. HBF were cultured in DMEM
supplemented with 0.1% BSA and with or without TGF-b1 (5 ng/
ml) for 7 days. Cells were stained with anti a-SMA antibody.
Mean fluorescence intensity of cells population (MFI) was
measured using cell cytometry. Results are calculated as
a ratio of MFI of TGF-b1 treated to MFI of untreated culture
(control) and presented as medians quartiles (n Z 7). The
statistical analysis was performed using two ways ANOVA,
)- p < 0.05 between groups of subjects (AS versus NA);
# - p < 0.01 between low density and high density cultures.
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blasts also reacted to the increased cell-seeding density with
a decreased level of fibroblast-to-myofibroblast differentia-
tion. However, in these cells, the effect was less pronounced
(Fig. 2A and B). These data were also confirmed by FACS
analyses. They revealed that asthmatic cells at the initial high
density displayed a significantly lower increase of a-SMA MFI
upon TGF-b1 stimulation, as compared with their counter-
parts seeded at the low density. It is worth noting that in cells
of AS group a-SMA content increased upon TGF-b1 stimulation
even in high density cultures, in contrast to cells of NA group
(Fig. 3). The same conclusions could be drawn from a-SMA
expression measured by immunoblotting (Fig. 4), which wasFigure 4 The expression of a-SMA in control and TGF-b1-
treated HBF of the NA and AS groups at low and high density.
Cells were cultured as described in Fig. 2. Protein extracts
(10 mg of protein per lane) were subjected to SDS-PAGE elec-
trophoresis and a-SMA protein/GAPDH was detected by
immunoblotting. Note the increased amount of a-SMA in TGF-
b1- treated cells in comparison to non-stimulated cells (derived
from both AS and NA group) and that immunodetectable a-SMA
was decreased considerably after high-density passage.the highest in TGF-b1-treated cells derived from AS group and
cultured at low cell density. All these results demonstrate
that the expression ofa-SMA depends both on cell density and
on cell origin and indicate that intercellular communication
affects cellular susceptibility to TGF-b1-induced FMT.
FMT in low density HBF cultures is not dependent
on the humoral factors
In search of the factors responsible for the increased reac-
tivity of bronchial fibroblasts to TGF-b1 in low-density
cultures, we focused on the possible inhibitory role of
autocrine factors secreted by confluent HBF. The sparse HBF
cultures, randomly chosen from the AS group, were sub-
jected to TGF-b1-stimulation in a medium conditioned by
dense HBF cultures derived from the same subject. As shown
in Fig. 5, no inhibitory effect of such a medium on the
induction of FMT was observed. This is illustrated by similar
percentages of a-SMA positive cells observed in TGF-b1-
supplemented with conditioned or fresh medium, respec-
tively. Similarly, no statistically significant differences in the
readiness of representative AS cells to differentiate into
myofibroblasts between control and serum-starved cells
were revealed (Fig. 6), indicating that contact-mediated
HBF quiescence is not involved in the observed desensitisa-
tion of dense fibroblasts to TGF-b1.
FMT is affected by N-cadherinedependent
intercellular adhesion
Thus, neither paracrine regulatory systems, nor the arrest
of the cell cycle, affected the efficacy of density-
dependent FMT of asthmatic HBF. Instead, these dataFigure 5 Asthmatics HBF grown at high density do not
secrete factors which inhibit the process of myofibroblast
differentiation. HBF from asthmatics were plated at low
density (5000 cells/cm2) and cultured in DMEM supplemented
with 0.1% BSA (fresh media) or in the fibroblast-conditional
medium (see Material and methods) derived from the same
subject (conditioned media) without or with 5 ng/ml TGF-b1.
After 7 days cells were fixed and stained for a-SMA. The
number of a -SMA positive cells was counted.
Figure 6 Fibroblast-to myofibroblast transition in low
density HBF cultures is not affected by G0/G1 phase arrest of
the cell cycle. HBF from asthmatics (AS: nZ 5) were plated at
density 3000 cells/cm2 and cultured in DMEM with 10% FCS for
24 h, then with serumefree DMEM supplemented with 0.1% BSA
for 5 days (starvation) or cells were plated at density
5000 cells/cm2 and cultured in DMEM with 10% FCS for 24 h
(control). After that as control cells as cells after serum star-
vation were culture in DMEM supplemented with 0.1% BSA and 5
ng/ml TGF-b1 for 5 or 7 days, respectively. The cells were fixed
and stained for a-SMA and the number of a-SMA positive cells
was counted.
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of FMT. As intercellular contacts between fibroblasts are,
among others, mediated by cell-surface, calcium-depen-
dent N-cadherin adhesion molecules, in subsequent
experiments we tested whether N-cadherin blocking anti-
body affected FMT. Cadherin-mediated intercellular
contacts are abundant upon confluence in HBF cultures.24
Unexpectedly, when N-cadherin blocking antibody was
added to the dense AS cell cultures it further inhibited the
process of density-dependent FMT (Fig. 7A). This observa-
tion suggests that binding of specific antibodies to N-cad-
herin molecules inhibits myofibroblasts formation in
a manner similar to that caused by cell-to-cell contacts. In
order to verify this hypothesis, we studied the effects of
N-cadherin specific blocking on FMT in sparse culture to
demonstrate that anti-N-cadherin antibody also inhibited
the process of FMT to the level characteristic for unstimu-
lated cultures (Fig. 7A). Moreover, N-cadherin blocking
affected actin cytoskeleton organisation, as revealed by
phalloidin staining. Cells grown in the N-cadherin blocked
conditions demonstrated less numerous and thinner stress
fibres (Fig. 7B). Altogether these observations indicate that
N-cadherin-mediated events are crucial for HBF trans-
differentiation.Discussion
Although the role of myofibroblasts during the development
of asthma is well established,12,25 the process of bronchial
wall remodelling in which these cells are involved remainslargely obscure, and the specific mechanisms determining
FMT in the asthma progression remain a matter of debate. It
is known that increased secretion of factors belonging to
TGF-b family by fibroblasts and infiltrating blood cells
accompanies the development of asthmatic chronic inflam-
mation.18,26 Therefore, it can be assumed that stimulation of
primary HBF in culture by TGF-b1 to some extend mimics the
milieu of fibroblasts in inflamed bronchial wall. Here, we
demonstrate that the intensity of FMT induced by TGF-b1
in vitro not only depends on the origin of analysed fibroblasts
(derived from non-asthmatic vs. asthmatic patients) but also
on the duration of TGF-b1 treatment. Moreover, this process
is positively affected by initial low cell densities, at the early
stages of HBF differentiation.
The striking difference observed between the suscepti-
bility of AS and NA fibroblasts to adopt myofibroblast
phenotype in response to TGF-b1 indicates that HBF derived
from asthmatic patients bear some predisposition, which
facilitates TGF-b1-induced FMT. We suggest that a prese-
lection might have occurred prior to the establishment of
HBF primary cultures which resulted in the formation of
subpopulation hyper-responsive to TGF-b signals. On the
other hand, there was no difference in HBF proliferation
rate in vitro between AS and NA groups (data not shown).
Similar results were obtained by Ward et al., who studied
the effect in larger groups of subjects.27 Thus, some factors
secreted in the early inflammatory foci might promote the
proliferation of specific fibroblast subpopulations in asth-
matic airways.13,28
Both AS and NA HBF were more apt to differentiate into
myofibroblasts in the prolonged exposure to TGF-b1
compared to short-term TGF-b1 treatment.
20 This is consis-
tent with the role of TGF-b1 in the aetiology of asthma.
15,26
These data show the necessity of developing experimental
models which maximally reflect the local HBF environment
in vivo and enable the precise control of FMT efficacy. We
claim that our experimental approach, based on the modu-
lation of initial cell density of AS and NA HBF cultured in the
presence of TGF-b1 and the duration of the experiment at
least partially reconstitutes the in vivo “asthmatic niche”. It
mimics early differentiation events crucial for the bronchial
wall cell FMT. Although it is difficult directly to compare the
spatial 3-D microenvironment of fibroblast in bronchial tissue
to the planar model of cells cultured in a plastic vessel, it is
evident that, at least in the initial stage of remodelling, the
fibroblasts are sparse in the healthy bronchial wall and do not
formmany cellecell contacts.Whenfibroblasts becomemore
abundant due to their enhanced proliferation and recruit-
ment of fibrocytes from the bloodstream or EMT,3,29 the
homophilic contactsbetween themaremore likely. It isworth
noting, that the main physiological role of fibroblasts adher-
ence junctions in vivomight be the transmission of a force to
ECM leading to tissue contraction e the process which may
contribute to the asthmatic attack or bronchi remodelling.
Local cell density has long been regarded as a factor
affecting the fate of normal cells.30 We show that both AS
and NA HBF reacted to the initial low densities in vitro with
the increase of TGF-b1 induced FMT. However this effect
was much more pronounced in AS HBF populations than in
their NA counterparts. This observation is in accordance
with the previous data on the direction of fibroblast
towards the myofibroblastic phenotype by the density at
Figure 7 Fibroblast-to myofibroblast transition in HBF cultures is affected by N-cadherinedependent intercellular adhesion. (A)
HBF from asthmatics were plated at low (5000 cells/cm2) and high (50,000 cells/cm2) density in DMEM with 10% FCS or in the same
medium containing the N-cadherin blocking antibody (dilution 1:100) for 24 h, and then with serum-free DMEM supplemented with
0.1% BSA and 5 ng/ml TGF-b1 without or with N-cadherin blocking antibody, respectively. After 7 days, the cells were fixed and
stained for a-SMA and the number of a-SMA positive cells was calculated. (B) Cells from representative asthmatic cultures were
photographed with Nomarski interference contrast optics and with epifluorescence mode. Bar Z 50 mm.
Asthmatic fibroblasts to myofibroblasts transition 1473which cells are plated.21,22,31 Furthermore, we proved using
our model system that neither HBF-conditioned medium
nor growth arrest in G0/G1 phase of cell cycle could stop
the TGF-b1-induced FMT in asthmatic cell populations.
Instead, the blocking of N-cadherin (a protein responsible
for formation and maturation of intercellular junctions and
creation of tension between cells24) in sparse asthmatic
HBF resulted in the inhibition of FMT. The question arises
about the mechanism of this phenomenon.Mechanical stress has long been described as a prereq-
uisite for the formation and the maintenance of stress
fibres and the incorporation of a-SMA into microfilament
bundles and subsequent development of differentiated
myofibroblast.10,14,32 Furthermore, focal adhesions were
implicated in the development of mechanical tension in
HBF cell populations.8,33,34 It was suggested that the orga-
nisation of N-cadherin based cellecell adhesions activated
Rho GTP-ase activity in many types of cells24,35 and that
1474 M. Michalik et al.Rho activation is crucial for FMT in lung fibroblasts.36 It is
thus possible that a low level of Rho activation in the
absence of N-cadherin cellecell contacts is insufficient for
development of a myofibroblastic phenotype. In general,
activation of small G protein Rho and its downstream
targets leads to activation of an actin-myosin system
(smooth muscle cell contraction) and development of
tension (fibroblasts stress fibres formation).10 Furthermore,
Rho proteins have recently been recognised as a possible
target for the treatment of airway hyper-responsiveness in
bronchial asthma.37
It should be stressed that the investigation of cell
behaviour for the elucidation of basic mechanisms respon-
sible for the arousal of such complex diseases as asthma can
only be reliably performed by employing model experi-
mental systems. The experimental model used in this study
mimics basic properties of bronchial fibroblasts during
asthma and the chronic inflammation crucial for this
disease. For example, typical Th2 cytokines produced
within asthmatic bronchial wall by infiltrating cells induce
prolonged production of TGF-b by structural cells in vivo.38
It is a hallmark of persistent asthmatic inflammation which
stimulates phenotypic changes of bronchial fibroblasts. In
our hands, HBF maintain their original phenotype and are
prone to TGF-b- induced FMT even following 5-15 divisions
in vitro. Such a reductionist approach enabled us to test for
between the groups differences in HBF susceptibility to
TGF-b1 - induced FMT, a topic very difficult to address by
studies using in vivo models. Whereas these data should be
verified using clinical approach, its is hard to expect simple
correlations due to the complexity of the disease.
Our results show for the first time that FMT in asthmatic
HBF populations is N-cadherin dependent, and can be
effectively decreased by inhibition of intercellular adhesion
junctions. The initial absence or an induced loss of
cellecell adhesions might be of special importance for an
inhibition of FMT, similarly to the situation observed in
epithelium.39,40 It was shown recently that, upon induction
by TGF-b, intestine fibroblasts overexpressed N-cadherin
and increased basal cell migration, which also was pre-
vented by N-cadherin inhibition.41 Even if this example
lacks its relevancy to the chronic bronchial disease, it
points to a general mechanism of wound healing as
a contributor to bronchial remodelling. Our findings
strongly suggest, that inhibition of N-cadherin or its
downstream targets, could be useful for anti-asthma
therapy not only because of reduction of bronchial
contraction driven by smooth muscle cells, but also by
diminishing FMT-dependent remodelling of the airway wall.Acknowledgements
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